Squarepoint Ops LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,454
-74.9%
12,815
-53.3%
0.00%
Q1 2023$73,579
-72.5%
27,455
-44.3%
0.00%
-100.0%
Q4 2022$267,775
-55.5%
49,314
+2.4%
0.00%
-66.7%
Q3 2022$602,000
+484.5%
48,181
+130.2%
0.00%
+200.0%
Q2 2022$103,000
+9.6%
20,926
+69.9%
0.00%
Q1 2022$94,000
-38.2%
12,319
-17.0%
0.00%
Q4 2021$152,000
-25.9%
14,839
+59.0%
0.00%
-100.0%
Q2 2021$205,000
-4.2%
9,332
-21.7%
0.00%
-50.0%
Q4 2020$214,000
-82.3%
11,919
-88.6%
0.00%
-87.5%
Q3 2020$1,207,000
+135.3%
104,468
+393.7%
0.02%
+100.0%
Q2 2020$513,000
-15.5%
21,160
-61.6%
0.01%
-50.0%
Q1 2020$607,000
+17.0%
55,084
+180.8%
0.02%
+433.3%
Q4 2019$519,000
-30.7%
19,618
-40.3%
0.00%
-57.1%
Q3 2019$749,000
+258.4%
32,871
+383.1%
0.01%
+250.0%
Q2 2019$209,000
-82.5%
6,804
-89.1%
0.00%
-85.7%
Q4 2018$1,192,000
-25.8%
62,233
+102.5%
0.01%
-26.3%
Q3 2018$1,607,000
+102.1%
30,735
+68.0%
0.02%
+72.7%
Q2 2018$795,00018,3000.01%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders